{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:46:52Z","timestamp":1793573212264,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000037","name":"Institute of Health Services and Policy Research","doi-asserted-by":"publisher","award":["PJT-517467"],"award-info":[{"award-number":["PJT-517467"]}],"id":[{"id":"10.13039\/501100000037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implement Sci Commun"],"DOI":"10.1186\/s43058-025-00837-3","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T23:26:36Z","timestamp":1766013996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study)"],"prefix":"10.1186","volume":"7","author":[{"given":"Meagan","family":"Mooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Weight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia J.","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kronfli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Elakpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Etherington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Greenaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Martel-Laferri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mendlowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-814X","authenticated-orcid":false,"given":"Guillaume","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"5","key":"837_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","volume":"7","author":"The Polaris Observatory HCV Collaborators","year":"2022","unstructured":"The Polaris Observatory HCV Collaborators. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022;7(5):396\u2013415. https:\/\/doi.org\/10.1016\/S2468-1253(21)00472-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"837_CR2","unstructured":"World Health Organization. Hepatitis C: Key facts.\u00a0https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c.\u00a0Accessed 4 Dec 2025."},{"issue":"5","key":"837_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1155\/2014\/317623","volume":"28","author":"RP Myers","year":"2014","unstructured":"Myers RP, Krajden M, Bilodeau M, et al. Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol. 2014;28(5):243\u201350. https:\/\/doi.org\/10.1155\/2014\/317623.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"837_CR4","unstructured":"Remis RS. Modelling the incidence and prevalence of hepatitis C infection and its sequelae in Canada, 2007. Community Acquired Infections Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2009. https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/sti-its-surv-epi\/model\/pdf\/model07-eng.pdf.\u00a0Accessed 4 Dec 2025."},{"key":"837_CR5","doi-asserted-by":"publisher","unstructured":"Trubnikov M, Yan P, Archibald C. Estimated prevalence of Hepatitis C Virus infection in Canada, 2011. Can Commun Dis Rep. 2014;40(19):429\u201336. https:\/\/doi.org\/10.14745\/ccdr.v40i19a02.","DOI":"10.14745\/ccdr.v40i19a02"},{"issue":"2","key":"837_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.22375","volume":"48","author":"HH Thein","year":"2008","unstructured":"Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology. 2008;48(2):418\u201331. https:\/\/doi.org\/10.1002\/hep.22375.","journal-title":"Hepatology"},{"key":"837_CR7","doi-asserted-by":"publisher","unstructured":"Amin J, Dore GJ, O'Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. Original research. J Hepatol. 2006;45(2):197\u2013203. S0168\u20138278(06)00167-X [pii]. https:\/\/doi.org\/10.1016\/j.jhep.2006.02.014.","DOI":"10.1016\/j.jhep.2006.02.014"},{"key":"837_CR8","unstructured":"Public Health Agency of Canada. Hepatitis C in Canada: 2005\u20132010 Surveillance Report. 2011.\u00a0https:\/\/publications.gc.ca\/collections\/collection_2012\/aspc-phac\/HP40-70-2012-eng.pdf.\u00a0Accessed 4 Dec 2025."},{"issue":"1","key":"837_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12879-016-1683-z","volume":"16","author":"NZ Janjua","year":"2016","unstructured":"Janjua NZ, Yu A, Kuo M, et al. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort. BMC Infect Dis. 2016;16(1):334. https:\/\/doi.org\/10.1186\/s12879-016-1683-z.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"837_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3138\/canlivj.2018-0011","volume":"1","author":"M Krajden","year":"2018","unstructured":"Krajden M, Cook D, Janjua NZ. Contextualizing Canada\u2019s hepatitis C virus epidemic. Canadian Liver Journal. 2018;1(4):218\u201330. https:\/\/doi.org\/10.3138\/canlivj.2018-0011.","journal-title":"Canadian Liver Journal"},{"issue":"4","key":"837_CR11","doi-asserted-by":"publisher","first-page":"E281","DOI":"10.9778\/cmajo.20140041","volume":"2","author":"M Trubnikov","year":"2014","unstructured":"Trubnikov M, Yan P, Njihia J, Archibald C. Identifying and describing a cohort effect in the national database of reported cases of hepatitis C virus infection in Canada (1991\u20132010): an age-period-cohort analysis. CMAJ Open. 2014;2(4):E281\u20137. https:\/\/doi.org\/10.9778\/cmajo.20140041.","journal-title":"CMAJ Open"},{"issue":"6\u20137","key":"837_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/00365540500525161","volume":"38","author":"HX Wu","year":"2006","unstructured":"Wu HX, Wu J, Wong T, et al. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004. Scand J Infect Dis. 2006;38(6\u20137):482\u20139. https:\/\/doi.org\/10.1080\/00365540500525161.","journal-title":"Scand J Infect Dis"},{"key":"837_CR13","unstructured":"Remis RS. A study to characterize the epidemiology of hepatitis C infection in Canada, 2002. Hepatitis C Prevention, Support and Research Program, Public Health Agency of Canada; 2008. https:\/\/publications.gc.ca\/collections\/collection_2009\/aspc-phac\/HP40-31-2008E.pdf.\u00a0Accessed 4 Dec 2025."},{"key":"837_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.drugalcdep.2018.06.013","volume":"190","author":"MR Skeer","year":"2018","unstructured":"Skeer MR, Ladin K, Wilkins LE, Landy DM, Stopka TJ. Hep c\u2019s like the common cold\u2019: understanding barriers along the HCV care continuum among young people who inject drugs. Drug Alcohol Depend. 2018;190:246\u201354. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.06.013.","journal-title":"Drug Alcohol Depend"},{"issue":"suppl_2","key":"837_CR15","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1093\/cid\/cit263","volume":"57","author":"C Treloar","year":"2013","unstructured":"Treloar C, Rance J, Backmund M. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clin Infect Dis. 2013;57(suppl_2):S51\u20135. https:\/\/doi.org\/10.1093\/cid\/cit263.","journal-title":"Clin Infect Dis"},{"issue":"10072","key":"837_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(17)30640-2","volume":"389","author":"T Lancet","year":"2017","unstructured":"Lancet T. Syndemics: health in context. Lancet. 2017;389(10072):881. https:\/\/doi.org\/10.1016\/S0140-6736(17)30640-2.","journal-title":"Lancet"},{"issue":"10072","key":"837_CR17","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0140-6736(17)30261-1","volume":"389","author":"SS Willen","year":"2017","unstructured":"Willen SS, Knipper M, Abad\u00eda-Barrero CE, Davidovitch N. Syndemic vulnerability and the right to health. Lancet. 2017;389(10072):964\u201377. https:\/\/doi.org\/10.1016\/S0140-6736(17)30261-1.","journal-title":"Lancet"},{"key":"837_CR18","unstructured":"The Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada. Report on hepatitis B and C in Canada: 2017.\u00a0https:\/\/www.canada.ca\/en\/services\/health\/publications\/diseases-conditions\/report-hepatitis-b-c-canada-2017.html.\u00a0Accessed 4 Dec 2025."},{"issue":"6","key":"837_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/QCO.0000000000000216","volume":"28","author":"M Hickman","year":"2015","unstructured":"Hickman M, De Angelis D, Vickerman P, Hutchinson S, Martin NK. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence. Curr Opin Infect Dis. 2015;28(6):576\u201382. https:\/\/doi.org\/10.1097\/QCO.0000000000000216.","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"837_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cld.626","volume":"9","author":"J Grebely","year":"2017","unstructured":"Grebely J, Dore GJ. Treatment of HCV in persons who inject drugs: treatment as prevention. Clin Liver Dis. 2017;9(4):77\u201380. https:\/\/doi.org\/10.1002\/cld.626.","journal-title":"Clin Liver Dis"},{"key":"837_CR21","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. 2022.\u00a0https:\/\/iris.who.int\/bitstream\/handle\/10665\/360348\/9789240053779-eng.pdf?sequence=1. Accessed 4 Dec 2025."},{"issue":"7","key":"837_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2468-1253(21)00077-7","volume":"6","author":"B Hajarizadeh","year":"2021","unstructured":"Hajarizadeh B, Grebely J, Byrne M, et al. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study. The Lancet Gastroenterology & Hepatology. 2021;6(7):533\u201346. https:\/\/doi.org\/10.1016\/S2468-1253(21)00077-7.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"837_CR23","unstructured":"Government of Canada. Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024\u20132030.\u00a0https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/diseases-conditions\/sexually-transmitted-blood-borne-infections-action-plan-2024-2030\/government-of-canada-stbbi-action-plan-final-en.pdf.\u00a0Accessed 4 Dec 2025."},{"key":"837_CR24","unstructured":"The Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups. Blueprint to inform hepatitis C elimination efforts in Canada. Canadian Network on Hepatitis C. 2019. https:\/\/www.canhepc.ca\/sites\/default\/files\/media\/documents\/blueprint_hcv_2019_05.pdf.\u00a0Accessed 4 Dec 2025."},{"key":"837_CR25","doi-asserted-by":"publisher","unstructured":"Grebely J, Matthews S, Causer LM, et al. We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what? Expert Rev Mol Diagn. Jan 4 2024:1-15. https:\/\/doi.org\/10.1080\/14737159.2023.2292645.","DOI":"10.1080\/14737159.2023.2292645"},{"key":"837_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugpo.2018.08.011","volume":"61","author":"S Bajis","year":"2018","unstructured":"Bajis S, Maher L, Treloar C, et al. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia. Int J Drug Policy. 2018;61:23\u201330. https:\/\/doi.org\/10.1016\/j.drugpo.2018.08.011.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"837_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2468-1253(17)30075-4","volume":"2","author":"J Grebely","year":"2017","unstructured":"Grebely J, Lamoury FMJ, Hajarizadeh B, et al. Evaluation of the Xpert HCV viral load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study. Lancet Gastroenterol Hepatol. 2017;2(7):514\u201320. https:\/\/doi.org\/10.1016\/S2468-1253(17)30075-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"837_CR28","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1093\/infdis\/jiy114","volume":"217","author":"FMJ Lamoury","year":"2018","unstructured":"Lamoury FMJ, Bajis S, Hajarizadeh B, et al. Evaluation of the Xpert HCV viral load finger-stick point-of-care assay. J Infect Dis. 2018;217(12):1889\u201396. https:\/\/doi.org\/10.1093\/infdis\/jiy114.","journal-title":"J Infect Dis"},{"issue":"3","key":"837_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S2468-1253(22)00346-6","volume":"8","author":"A Trickey","year":"2023","unstructured":"Trickey A, Fajardo E, Alemu D, Artenie AA, Easterbrook P. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(3):253\u201370. https:\/\/doi.org\/10.1016\/S2468-1253(22)00346-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"837_CR30","doi-asserted-by":"publisher","unstructured":"Toskin I, Peeling RW, Mabey D, et al. Point-of-care tests for STIs: the way forward. Sex Transm Infect. 2017;93(S4):S1\u2013S2. https:\/\/doi.org\/10.1136\/sextrans-2016-053074.","DOI":"10.1136\/sextrans-2016-053074"},{"key":"837_CR31","unstructured":"CATIE. Hepatitis C point-of-care testing: What is its impact on testing and linkage to care?\u00a0https:\/\/www.catie.ca\/prevention-in-focus\/hepatitis-c-point-of-care-testing-what-is-its-impact-on-testing-and-linkage-0.\u00a0Accessed 17 Sept 2025."},{"key":"837_CR32","unstructured":"Health Canada grants licence to Cepheid\u2019s HCV test. Medical Device Network. https:\/\/www.medicaldevice-network.com\/news\/health-canada-cepheid-hcv-test\/?cf-view.\u00a0Accessed 12 Sept 2025."},{"key":"837_CR33","unstructured":"CATIE. New hepatitis C point-of-care tests approved by Health Canada.\u00a0https:\/\/www.catie.ca\/catie-news\/new-hepatitis-c-point-of-care-tests-approved-by-health-canada.\u00a0Accessed 17 Sept 2025."},{"key":"837_CR34","unstructured":"World Health Organization. Updated recommendations on HCV simplified service delivery and HCV diagnostics: policy brief. World Health Organization; 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240052697.\u00a0Accessed 4 Dec 2025."},{"issue":"1\u20132","key":"837_CR35","doi-asserted-by":"publisher","first-page":"100014","DOI":"10.1139\/cjm-2022-0204","volume":"1","author":"G Johnson","year":"2021","unstructured":"Johnson G, Zubrzycki A, Henry M, et al. Clinical evaluation of the genexpert\u00ae xpert\u00ae xpress SARS-CoV-2\/flu\/RSV combination test. J Clin Virol Plus. 2021;1(1\u20132):100014.\u00a0https:\/\/doi.org\/10.1139\/cjm-2022-0204.","journal-title":"J Clin Virol Plus"},{"issue":"5","key":"837_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","volume":"7","author":"EB Cunningham","year":"2022","unstructured":"Cunningham EB, Wheeler A, Hajarizadeh B, et al. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(5):426\u201345.\u00a0https:\/\/doi.org\/10.1016\/S2468-1253(21)00471-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"837_CR37","doi-asserted-by":"publisher","unstructured":"Grebely J, Gilliver R, McNaughton T, et al. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study. Int J Drug Policy. 2023;114:103982. https:\/\/doi.org\/10.1016\/j.drugpo.2023.103982.","DOI":"10.1016\/j.drugpo.2023.103982"},{"key":"837_CR38","doi-asserted-by":"publisher","unstructured":"Lettner B, Mason K, Greenwald ZR, et al. Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort study. The Lancet Regional Health \u2013 Americas. 2023;22https:\/\/doi.org\/10.1016\/j.lana.2023.100490.","DOI":"10.1016\/j.lana.2023.100490"},{"issue":"3","key":"837_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jhep.2023.04.019","volume":"79","author":"Y Sheehan","year":"2023","unstructured":"Sheehan Y, Cunningham EB, Cochrane A, et al. One-stop-shop\u2019 point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study. J Hepatol. 2023;79(3):635\u201344. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.019.","journal-title":"J Hepatol"},{"issue":"10","key":"837_CR40","doi-asserted-by":"publisher","first-page":"e2338792","DOI":"10.1001\/jamanetworkopen.2023.38792","volume":"6","author":"MD Morris","year":"2023","unstructured":"Morris MD, McDonell C, Luetkemeyer AF, Thawley R, McKinney J, Price JC. Community-based point-of-diagnosis hepatitis c treatment for marginalized populations: a nonrandomized controlled trial. JAMA Netw Open. 2023;6(10):e2338792\u2013e2338792. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.38792.","journal-title":"JAMA Netw Open"},{"key":"837_CR41","doi-asserted-by":"publisher","first-page":"104185","DOI":"10.1016\/j.drugpo.2023.104185","volume":"121","author":"J Demant","year":"2023","unstructured":"Demant J, Krohn-Dehli L, Van der Veen J, \u00d8vrehus A, Lazarus JV, Weis N. Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark. Int J Drug Policy. 2023;121:104185.\u00a0https:\/\/doi.org\/10.1016\/j.drugpo.2023.104185.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"837_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/apc.2020.0077","volume":"34","author":"T Magel","year":"2020","unstructured":"Magel T, Conway B. Targeted outreach, education, and point-of-care testing for HIV and hepatitis C: strategies to address HIV infection in marginalized communities in Vancouver. AIDS Patient Care STDS. 2020;34(7):281\u20133. https:\/\/doi.org\/10.1089\/apc.2020.0077.","journal-title":"AIDS Patient Care STDS"},{"key":"837_CR43","doi-asserted-by":"publisher","first-page":"102921","DOI":"10.1016\/j.drugpo.2020.102921","volume":"85","author":"N Kronfli","year":"2020","unstructured":"Kronfli N, Dussault C, Chalifoux S, Kavoukian H, Klein MB, Cox J. A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada. Int J Drug Policy. 2020;85:102921. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102921.","journal-title":"Int J Drug Policy"},{"key":"837_CR44","doi-asserted-by":"publisher","first-page":"104720","DOI":"10.1016\/j.drugpo.2025.104720","volume":"137","author":"A Stevens","year":"2025","unstructured":"Stevens A, Lafferty L, Treloar C, et al. Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection. Int J Drug Policy. 2025;137:104720. https:\/\/doi.org\/10.1016\/j.drugpo.2025.104720.","journal-title":"Int J Drug Policy"},{"key":"837_CR45","doi-asserted-by":"publisher","first-page":"104871","DOI":"10.1016\/j.drugpo.2025.104871","volume":"143","author":"A Stevens","year":"2025","unstructured":"Stevens A, Abbott J, Gribbin L, et al. Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT study. Int J Drug Policy. 2025;143:104871. https:\/\/doi.org\/10.1016\/j.drugpo.2025.104871.","journal-title":"Int J Drug Policy"},{"key":"837_CR46","doi-asserted-by":"publisher","first-page":"103456","DOI":"10.1016\/j.drugpo.2021.103456","volume":"99","author":"L Lafferty","year":"2022","unstructured":"Lafferty L, Cochrane A, Sheehan Y, Treloar C, Grebely J, Lloyd AR. That was quick, simple, and easy\": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison. Int J Drug Policy. 2022;99:103456. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103456.","journal-title":"Int J Drug Policy"},{"key":"837_CR47","doi-asserted-by":"publisher","first-page":"103345","DOI":"10.1016\/j.drugpo.2021.103345","volume":"96","author":"L Duchesne","year":"2021","unstructured":"Duchesne L, Dussault C, Godin A, Maheu-Giroux M, Kronfli N. Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis. Int J Drug Policy. 2021;96:103345. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103345.","journal-title":"Int J Drug Policy"},{"key":"837_CR48","doi-asserted-by":"publisher","first-page":"100750","DOI":"10.1016\/j.lanwpc.2023.100750","volume":"36","author":"STF Shih","year":"2023","unstructured":"Shih STF, Cheng Q, Carson J, et al. Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis. Lancet Reg Health. 2023;36:100750. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100750.","journal-title":"Lancet Reg Health"},{"issue":"1","key":"837_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15381501003661513","volume":"9","author":"SR Henry","year":"2010","unstructured":"Henry SR, Hagedorn HJ, Feld JE, et al. A formative evaluation of organizational readiness to implement nurse-initiated HIV rapid testing in two veterans health administration substance use disorder clinics. J HIV AIDS Soc Serv. 2010;9(1):7\u201326.","journal-title":"J HIV AIDS Soc Serv"},{"issue":"3","key":"837_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/POC.0000000000000056","volume":"14","author":"NP Pai","year":"2015","unstructured":"Pai NP, Wilkinson S, Deli-Houssein R, et al. Barriers to implementation of rapid and point-of-care tests for human immunodeficiency virus infection: findings from a systematic review (1996\u20132014). Point of Care: The Journal of Near-Patient Testing & Technology. 2015;14(3):81\u20137.","journal-title":"Point of Care: The Journal of Near-Patient Testing & Technology"},{"issue":"11","key":"837_CR51","doi-asserted-by":"publisher","first-page":"e009408","DOI":"10.1136\/bmjgh-2022-009408","volume":"7","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Guy R, Camara H, et al. Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: a systematic review. BMJ Glob Health. 2022;7(11):e009408.","journal-title":"BMJ Glob Health"},{"issue":"8","key":"837_CR52","doi-asserted-by":"publisher","first-page":"e0135112","DOI":"10.1371\/journal.pone.0135112","volume":"10","author":"N Engel","year":"2015","unstructured":"Engel N, Ganesh G, Patil M, et al. Barriers to point-of-care testing in India: results from qualitative research across different settings, users and major diseases. PLoS ONE. 2015;10(8):e0135112.","journal-title":"PLoS ONE"},{"key":"837_CR53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fpubh.2017.00076","volume":"5","author":"A Minichiello","year":"2017","unstructured":"Minichiello A, Swab M, Chongo M, et al. HIV point-of-care testing in Canadian settings: a scoping review. Front Public Health. 2017;5:76.","journal-title":"Front Public Health"},{"issue":"3","key":"837_CR54","doi-asserted-by":"publisher","first-page":"e0265173","DOI":"10.1371\/journal.pone.0265173","volume":"17","author":"A Pacho","year":"2022","unstructured":"Pacho A, Harding-Esch EM, Heming De-Allie EG, et al. Facilitators and barriers for clinical implementation of a 30-minute point-of-care test for Neisseria gonorrhoeae and Chlamydia trachomatis into clinical care: a qualitative study within sexual health services in England. PLoS ONE. 2022;17(3):e0265173.","journal-title":"PLoS ONE"},{"issue":"4","key":"837_CR55","doi-asserted-by":"publisher","first-page":"e006922","DOI":"10.1136\/bmjopen-2014-006922","volume":"5","author":"L Natoli","year":"2015","unstructured":"Natoli L, Guy R, Shephard M, et al. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. BMJ Open. 2015;5(4):e006922.","journal-title":"BMJ Open"},{"issue":"1","key":"837_CR56","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12879-022-07534-9","volume":"22","author":"K Martin","year":"2022","unstructured":"Martin K, Wenlock R, Roper T, Butler C, Vera JH. Facilitators and barriers to point-of-care testing for sexually transmitted infections in low-and middle-income countries: a scoping review. BMC Infect Dis. 2022;22(1):561.","journal-title":"BMC Infect Dis"},{"key":"837_CR57","doi-asserted-by":"publisher","unstructured":"Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low-and middle-income countries. PLoS Med. 2012;9(9):e1001306. https:\/\/doi.org\/10.1371\/journal.pmed.1001306.","DOI":"10.1371\/journal.pmed.1001306"},{"key":"837_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:1\u201315.","journal-title":"Implement Sci"},{"issue":"1","key":"837_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):75.","journal-title":"Implement Sci"},{"key":"837_CR60","doi-asserted-by":"publisher","first-page":"905909","DOI":"10.3389\/frhs.2022.905909","volume":"2","author":"N Nathan","year":"2022","unstructured":"Nathan N, Powell BJ, Shelton RC, et al. Do the expert recommendations for implementing change (ERIC) strategies adequately address sustainment? Front Health Serv. 2022;2:905909.","journal-title":"Front Health Serv"},{"key":"837_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:1\u201314.","journal-title":"Implement Sci"},{"issue":"1","key":"837_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev-psych-032620-035725","volume":"75","author":"B Mustanski","year":"2024","unstructured":"Mustanski B, Queiroz A, Merle JL, et al. A systematic review of implementation research on determinants and strategies of effective HIV interventions for men who have sex with men in the United States. Annu Rev Psychol. 2024;75(1):55\u201385.","journal-title":"Annu Rev Psychol"},{"key":"837_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-017-0588-6","volume":"12","author":"SS Rogal","year":"2017","unstructured":"Rogal SS, Yakovchenko V, Waltz TJ, et al. The association between implementation strategy use and the uptake of hepatitis C treatment in a national sample. Implement Sci. 2017;12:1\u201313.","journal-title":"Implement Sci"},{"issue":"2","key":"837_CR64","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/hep.32395","volume":"76","author":"V Yakovchenko","year":"2022","unstructured":"Yakovchenko V, Morgan TR, Miech EJ, et al. Core implementation strategies for improving cirrhosis care in the Veterans Health Administration. Hepatology. 2022;76(2):404\u201317.","journal-title":"Hepatology"},{"issue":"1","key":"837_CR65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13012-024-01398-0","volume":"19","author":"G Fontaine","year":"2024","unstructured":"Fontaine G, Vinette B, Weight C, et al. Effects of implementation strategies on nursing practice and patient outcomes: a comprehensive systematic review and meta-analysis. Implement Sci. 2024;19(1):68. https:\/\/doi.org\/10.1186\/s13012-024-01398-0.","journal-title":"Implement Sci"},{"key":"837_CR66","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fpubh.2019.00158","volume":"7","author":"ME Fernandez","year":"2019","unstructured":"Fernandez ME, Ten Hoor GA, Van Lieshout S, et al. Implementation mapping: using intervention mapping to develop implementation strategies. Front Public Health. 2019;7:158.","journal-title":"Front Public Health"},{"key":"837_CR67","doi-asserted-by":"publisher","unstructured":"Fernandez ME, Powell BJ, Ten Hoor GA. Editorial: Implementation Mapping for selecting, adapting and developing implementation strategies. Front Public Health. 2023;11:1288726. https:\/\/doi.org\/10.3389\/fpubh.2023.1288726.","DOI":"10.3389\/fpubh.2023.1288726"},{"key":"837_CR68","doi-asserted-by":"publisher","unstructured":"Pinnock H, Barwick M, Carpenter CR, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ. 2017;356:i6795. https:\/\/doi.org\/10.1136\/bmj.i6795.","DOI":"10.1136\/bmj.i6795"},{"key":"837_CR69","doi-asserted-by":"publisher","unstructured":"Hoefer R. The Multiple Streams Framework: Understanding and Applying the Problems, Policies, and Politics Approach. J Policy Pract Res. 2022;3(1):1\u20135. https:\/\/doi.org\/10.1007\/s42972-022-00049-2.","DOI":"10.1007\/s42972-022-00049-2"},{"key":"837_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-7-37","volume":"7","author":"J Cane","year":"2012","unstructured":"Cane J, O\u2019Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:1\u201317.","journal-title":"Implement Sci"},{"key":"837_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-017-0605-9","volume":"12","author":"L Atkins","year":"2017","unstructured":"Atkins L, Francis J, Islam R, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12:1\u201318.","journal-title":"Implement Sci"},{"key":"837_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-016-0534-z","volume":"12","author":"SA Birken","year":"2017","unstructured":"Birken SA, Powell BJ, Presseau J, et al. Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review. Implement Sci. 2017;12:1\u201314.","journal-title":"Implement Sci"},{"issue":"1","key":"837_CR73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13012-022-01227-2","volume":"17","author":"S McHugh","year":"2022","unstructured":"McHugh S, Presseau J, Luecking CT, Powell BJ. Examining the complementarity between the ERIC compilation of implementation strategies and the behaviour change technique taxonomy: a qualitative analysis. Implement Sci. 2022;17(1):56.","journal-title":"Implement Sci"},{"issue":"1","key":"837_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13012-019-0892-4","volume":"14","author":"TJ Waltz","year":"2019","unstructured":"Waltz TJ, Powell BJ, Fernandez ME, Abadie B, Damschroder LJ. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci. 2019;14(1):42. https:\/\/doi.org\/10.1186\/s13012-019-0892-4.","journal-title":"Implement Sci"},{"key":"837_CR75","doi-asserted-by":"publisher","unstructured":"Taylor N, Mazariego C, Baffsky R, et al. Advancing the Speed and Science of Implementation Using Mixed-Methods Process Mapping \u2013 Best Practice Recommendations. Int J Qual Methods. 2025;24. https:\/\/doi.org\/10.1177\/16094069251340908.","DOI":"10.1177\/16094069251340908"},{"issue":"2","key":"837_CR76","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pec.2010.04.034","volume":"82","author":"G Elwyn","year":"2011","unstructured":"Elwyn G, Kreuwel I, Durand MA, et al. How to develop web-based decision support interventions for patients: a process map. Patient Educ Couns. 2011;82(2):260\u20135. https:\/\/doi.org\/10.1016\/j.pec.2010.04.034.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"837_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s43058-020-00094-6","volume":"1","author":"J Kononowech","year":"2020","unstructured":"Kononowech J, Landis-Lewis Z, Carpenter J, et al. Visual process maps to support implementation efforts: a case example. Implement Sci Commun. 2020;1(1):105. https:\/\/doi.org\/10.1186\/s43058-020-00094-6.","journal-title":"Implement Sci Commun"},{"issue":"1","key":"837_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-019-3457-6","volume":"20","author":"A Morrow","year":"2019","unstructured":"Morrow A, Hogden E, Kang Y-J, et al. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol. Trials. 2019;20(1):1\u201312.","journal-title":"Trials"},{"issue":"1","key":"837_CR79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13012-019-0951-x","volume":"14","author":"J Presseau","year":"2019","unstructured":"Presseau J, McCleary N, Lorencatto F, Patey AM, Grimshaw JM, Francis JJ. Action, actor, context, target, time (AACTT): a framework for specifying behaviour. Implement Sci. 2019;14(1):102. https:\/\/doi.org\/10.1186\/s13012-019-0951-x.","journal-title":"Implement Sci"},{"issue":"1","key":"837_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-017-0635-3","volume":"12","author":"BJ Weiner","year":"2017","unstructured":"Weiner BJ, Lewis CC, Stanick C, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12(1):1\u201312.","journal-title":"Implement Sci"},{"issue":"1","key":"837_CR81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1748-5908-9-7","volume":"9","author":"CM Shea","year":"2014","unstructured":"Shea CM, Jacobs SR, Esserman DA, Bruce K, Weiner BJ. Organizational readiness for implementing change: a psychometric assessment of a new measure. Implement Sci. 2014;9(1):7. https:\/\/doi.org\/10.1186\/1748-5908-9-7.","journal-title":"Implement Sci"},{"issue":"1","key":"837_CR82","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1186\/s12889-024-18270-x","volume":"24","author":"G Fontaine","year":"2024","unstructured":"Fontaine G, Smith M, Langmuir T, et al. One size doesn\u2019t fit all: methodological reflections in conducting community-based behavioural science research to tailor COVID-19 vaccination initiatives for public health priority populations. BMC Public Health. 2024;24(1):784.","journal-title":"BMC Public Health"},{"issue":"1","key":"837_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s43058-023-00424-4","volume":"4","author":"ZM Salvati","year":"2023","unstructured":"Salvati ZM, Rahm AK, Williams MS, et al. A picture is worth a thousand words: advancing the use of visualization tools in implementation science through process mapping and matrix heat mapping. Implement Sci Commun. 2023;4(1):43.","journal-title":"Implement Sci Commun"},{"key":"837_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-7-38","volume":"7","author":"SD French","year":"2012","unstructured":"French SD, Green SE, O\u2019Connor DA, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework. Implement Sci. 2012;7:1\u20138.","journal-title":"Implement Sci"},{"key":"837_CR85","doi-asserted-by":"crossref","unstructured":"Kaplan R, Anderson S. Time-driven activity-based costing (SSRN Scholarly Paper ID 485443). Social Science Research Network Retrieved from. 2003;485443. https:\/\/dx.doi.org\/10.2139\/ssrn.485443.","DOI":"10.2139\/ssrn.485443"},{"issue":"7","key":"837_CR86","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jval.2019.01.018","volume":"22","author":"TR McClintock","year":"2019","unstructured":"McClintock TR, Shah MA, Chang SL, Haleblian GE. Time-driven activity-based costing in urologic surgery cycles of care. Value Health. 2019;22(7):768\u201371. https:\/\/doi.org\/10.1016\/j.jval.2019.01.018.","journal-title":"Value Health"}],"updated-by":[{"DOI":"10.1186\/s43058-026-01014-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000}}],"container-title":["Implementation Science Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-025-00837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43058-025-00837-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-025-00837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:29:09Z","timestamp":1781764149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43058-025-00837-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1186\/s43058-025-00837-3","relation":{},"ISSN":["2662-2211"],"issn-type":[{"value":"2662-2211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article has been updated to correct the Competing Interests statement.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s43058-026-01014-w","URL":"https:\/\/doi.org\/10.1186\/s43058-026-01014-w","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study described above was reviewed and approved by the Research Ethics Board of McGill University, Faculty of Medicine and Health Sciences (protocol # 24-12-038). See\n                      Additional file 4\n                      for REB approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; no data are contained in this study protocol paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NK reports investigator-initiated studies from ViiV Healthcare, Abbvie, and Gilead, and honoraria from Abbvie, all outside this work. JB reports investigator-initiated studies from Gilead, and honoraria from Gilead and Abbvie, all outside this work. JG has received research grants, speaker fees, and participated on advisory boards for AbbVie, Abbott, bioLytical, Cepheid, Gilead Sciences, Hologic, and Roche. GF reports speaker fees\/hospitality from Gilead and Abbvie, all outside this work and is an Associate Editor of Implementation Science Communications.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}